Test Directory

Test Code
2450
Test Name
Caffey Disease
CPT Codes
81408, 81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Description

Caffey disease (MIM 114000) including infantile and prenatal cortical hyperostosis is an autosomal dominant disorder.  It is characterized by massive subperiosteal bone formation.  Caffey disease has a variable prognosis that is dependent on the age of presentation.  Infantile cortical hyperostosis is a benign disorder usually presenting before 5 months of age.  The acute manifestations in infantile cortical hyperostosis are typically inflammatory in nature with painful swelling of the involved bone accompanied by fever, elevated white blood cell count and elevated erythrocyte sedimentation rate.   The bones involved are variable but the tibia has been reported to be affected in many patients.  Although some adult patients with infantile cortical hyperostosis have been described, it often spontaneously resolves before two years of age.   Adult patients have also been described with the Ehlers-Danlos like symptoms of joint laxity, hyperextensible skin and inguinal hernia. In contrast to the infantile presentation, prenatal cortical hyperostosis is a lethal disorder.  When detected prenatally, Caffey disease or prenatal cortical hyperostosis, may be confused with lethal osteogenesis imperfecta.  In addition to cortical hyperostosis, angulation of long bones and irregularities of the ribs may be visualized. Polyhydramnios, anasarca and pulmonary hypoplasia are also clinical features of prenatal cortical hyperostosis.  The infantile form and at least some cases of the prenatal form of cortical hyperostosis are caused by a specific mutation in the COL1A1 gene.

Testing Schedule
Monday-Friday
Genes
COL1A1
MIM
114000
Disease Group
Skeletal Disorders